Skip to content

Clinical trials

Completed Alzheimer Disease trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Serbia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20131
20143
20151
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.2
ACADIA Pharmaceuticals Inc.1
Avraham Pharmaceuticals Ltd1
Axovant Sciences Ltd.1
Eli Lilly and Company1
FORUM Pharmaceuticals Inc1
H. Lundbeck A/S1
Kyowa Kirin Co., Ltd.1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease10
Dementia5
Cognitive Dysfunction3
Mental Disorders3
Nervous System Diseases3
Central Nervous System Diseases2
Psychomotor Agitation2
Anxiety Disorders1
Brain Diseases1
Corticobasal Degeneration1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.